UA143609U - Катализатор ионообменных процессов - Google Patents
Катализатор ионообменных процессов Download PDFInfo
- Publication number
- UA143609U UA143609U UAU201912160U UAU201912160U UA143609U UA 143609 U UA143609 U UA 143609U UA U201912160 U UAU201912160 U UA U201912160U UA U201912160 U UAU201912160 U UA U201912160U UA 143609 U UA143609 U UA 143609U
- Authority
- UA
- Ukraine
- Prior art keywords
- ozone
- ion exchange
- voltage
- kyiv
- ukraine
- Prior art date
Links
- 238000005342 ion exchange Methods 0.000 title claims abstract description 6
- 239000003054 catalyst Substances 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 22
- 230000003068 static effect Effects 0.000 claims abstract description 3
- 230000005684 electric field Effects 0.000 claims abstract 2
- 238000011161 development Methods 0.000 claims description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 17
- 150000002500 ions Chemical class 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 238000001802 infusion Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000010891 electric arc Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000007788 Acute Liver Failure Diseases 0.000 description 1
- 206010000804 Acute hepatic failure Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 201000009859 Osteochondrosis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 231100000836 acute liver failure Toxicity 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001959 cardiohemodynamic effect Effects 0.000 description 1
- 239000008148 cardioplegic solution Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000001031 fetal erythroblastosis Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000015323 positive regulation of phagocytosis Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000701 toxic element Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201912160U UA143609U (ru) | 2019-12-23 | 2019-12-23 | Катализатор ионообменных процессов |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201912160U UA143609U (ru) | 2019-12-23 | 2019-12-23 | Катализатор ионообменных процессов |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA143609U true UA143609U (ru) | 2020-08-10 |
Family
ID=72339513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201912160U UA143609U (ru) | 2019-12-23 | 2019-12-23 | Катализатор ионообменных процессов |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA143609U (ru) |
-
2019
- 2019-12-23 UA UAU201912160U patent/UA143609U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Harakawa et al. | Effects of a 50 Hz electric field on plasma lipid peroxide level and antioxidant activity in rats | |
| CN1359296A (zh) | 氙治疗神经中毒的用途 | |
| US5232441A (en) | Method of treating schistosomal infestations by iontophoresis | |
| Bocci et al. | Mechanisms of action and chemical-biological interactions between ozone and body compartments: a critical appraisal of the different administration routes | |
| Jani et al. | Ozone therapy: the alternative medicine of future | |
| UA143609U (ru) | Катализатор ионообменных процессов | |
| COHEN et al. | Effect of diazepam and meperidine, alone and in combination, on respiratory response to carbon dioxide | |
| WO2021133367A1 (ru) | Способ интенсификации ионообменных процессов | |
| Singh et al. | Role of ozone therapy and cancer: myth or reality | |
| Pawluk et al. | Power Tools for Health: How pulsed magnetic fields (PEMFs) help you | |
| Heymans et al. | On new nicotinolytic compounds | |
| Steenken Jr | Streptomycin in guinea pig tuberculosis | |
| RU2676836C2 (ru) | Устройство для лечения недостаточности иммунных функций и регулирования метаболизма | |
| CN104547150A (zh) | 消炎止痛外用药做为肿瘤、痈疮治疗口服剂的应用 | |
| Sopuev et al. | An experimental evaluation of the effectiveness of dissociative anti-adhesive products | |
| Yassin et al. | Ozone Injection Therapy Compared with Corticosteroid Injections for Knee Osteoarthritis | |
| RU2363507C1 (ru) | Способ детоксикации организма при отравлении нембуталом | |
| Zamora et al. | Inhibition of tumor necrosis factor-alpha release during endotoxic shock by ozone oxidative preconditioning in mice | |
| CN106667907A (zh) | 一种广谱抗肿瘤复合制剂 | |
| RU2284838C1 (ru) | Способ лечения хронической лимфатической недостаточности нижних конечностей | |
| Strandberg et al. | Protective effect of polyphloretin phosphate in anaphylaxis in the guinea pig | |
| RU2315638C1 (ru) | Способ комплексного лечения воспалительных заболеваний мочеполовых органов мужчин | |
| Armstrong et al. | Effect of promin on experimental tuberculosis | |
| RADE | Ozone Therapy. | |
| Vasil'ev et al. | The pharmacology of some high-molecular polysaccharides |